How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Site Laboratory Service Market
- By Service Type: Sample Collection and Handling, Analytical Testing, Data Management and Reporting, Equipment Calibration and Maintenance, Quality Control and Assurance
- By End-User Industry: Pharmaceutical and Biotechnology, Environmental Monitoring, Food and Beverage, Chemical Manufacturing, Oil and Gas
- By Sample Type: Soil Samples, Water Samples, Air Samples, Biological Samples, Chemical Samples
- By Deployment Model: On-site Mobile Laboratories, Fixed On-site Laboratories, Third-party Contract Laboratories
- By Testing Technology: Chromatography, Spectroscopy, Microbiological Testing, Molecular Diagnostics, Immunoassays
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Sample Collection and Handling leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.183 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.191 →
Full report · locked preview
Everything inside the Site Laboratory Service Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
End-User Industry 5
Sample Type 5
Deployment Model 3
Testing Technology 5
Companies profiled
LabCorp (Laboratory Corporation of America Holdings)
Quest Diagnostics Incorporated
ICON plc
PPD
Inc. (Pharmaceutical Product Development)
Covance Inc. (a LabCorp company)
Charles River Laboratories International Inc.
Eurofins Scientific
PRA Health Sciences (now part of ICON plc)
Medpace Holdings Inc.
Syneos Health Inc.
BioAgilytix Labs
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →LabCorp (Laboratory Corporation of America Holdings)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Quest Diagnostics Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →ICON plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →PPD
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Inc. (Pharmaceutical Product Development)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Covance Inc. (a LabCorp company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Charles River Laboratories International Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Eurofins Scientific
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →PRA Health Sciences (now part of ICON plc)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Medpace Holdings Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Syneos Health Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →BioAgilytix Labs
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Q2 Solutions (a joint venture between IQVIA and Quest Diagnostics)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Pharmaron
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Frontage Laboratories Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →WuXi AppTec
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,974M by 2033 · 6.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Sample Collection and Handling38.9
- Analytical Testing17.2
- Data Management and Reporting13.5
- Equipment Calibration and Maintenance14.1
- Quality Control and Assurance16.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$578.3M → $985.2M · 6.9%
Europe$403.0M → $688.1M · 6.9%
Asia Pacific$368.0M → $680.6M · 8.0%
Latin America$227.8M → $403.9M · 7.4%
Middle East and Africa$175.2M → $288.3M · 6.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.792026
6.802027
6.812028
6.822029
6.832030
6.852031
6.852032
6.882033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- LabCorp (Laboratory Corporation of America Holdings)15.8
- Quest Diagnostics Incorporated9.7
- ICON plc10.5
- PPD10.3
- Inc. (Pharmaceutical Product Development)13.8
- Covance Inc. (a LabCorp company)11.9
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type23.2%
End-User Industry24.5%
Sample Type9.5%
Deployment Model23.5%
Testing Technology19.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.3
- Europe22.6
- Asia Pacific22.3
- Latin America13.3
- Middle East and Africa9.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| LabCorp (Laboratory Corporation of America Holdings) | 79 | 90 | 99 | 93 | 86 | 96 | 91 |
| Quest Diagnostics Incorporated | 85 | 83 | 76 | 85 | 83 | 80 | 82 |
| ICON plc | 76 | 68 | 79 | 66 | 63 | 83 | 73 |
| PPD | 72 | 65 | 80 | 61 | 78 | 64 | 70 |
| Inc. (Pharmaceutical Product Development) | 72 | 67 | 70 | 74 | 56 | 52 | 65 |
| Covance Inc. (a LabCorp company) | 57 | 48 | 46 | 47 | 70 | 55 | 54 |
| Charles River Laboratories International Inc. | 57 | 59 | 48 | 50 | 53 | 48 | 53 |
| Eurofins Scientific | 56 | 53 | 37 | 41 | 58 | 59 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- LabCorp (Laboratory Corporation of America Holdings)
- Quest Diagnostics Incorporated
- ICON plc
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| LabCorp (Laboratory Corporation of America Holdings) | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Quest Diagnostics Incorporated | ✓ | ✓ | ◐ | ◐ | ✓ | ✓ |
| ICON plc | ◐ | ◐ | ✓ | ✓ | − | ◐ |
| PPD | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| Inc. (Pharmaceutical Product Development) | − | − | ✓ | ◐ | ◐ | − |
| Covance Inc. (a LabCorp company) | − | ◐ | ◐ | − | ◐ | ◐ |
| Charles River Laboratories International Inc. | − | − | − | − | ◐ | − |
| Eurofins Scientific | ◐ | ◐ | − | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1LabCorp (Laboratory Corporation of America Holdings)91
2Quest Diagnostics Incorporated82
3ICON plc73
4PPD70
5Inc. (Pharmaceutical Product Development)65
6Covance Inc. (a LabCorp company)54
7Charles River Laboratories International Inc.53
8Eurofins Scientific51
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
LabCorp (Laboratory Corporation of America Holdings)Quest Diagnostics Incorporated
Challenger2
Strong scale, closing on the leaders.
ICON plcPPD
Contender1
Focused players with pockets of strength.
Inc. (Pharmaceutical Product Development)
Niche3
Specialists in a single segment or region.
Covance Inc. (a LabCorp company)Charles River Laboratories International Inc.Eurofins Scientific
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Site Laboratory Service Market — a $494M beachhead inside a $8.28B market.
Beachhead (SOM)$494Mobtainable near-term
Serviceable (SAM)$2.86Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Sample Collection and Handling
Best fit — highest urgency & budget in Service Type.
Economic buyer80 fit
Analytical Testing
Strong fit — clear ROI and a fast path to value.
End user64 fit
Data Management and Reporting
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-User Industry & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Sample Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Site Laboratory Service Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified21%
Evaluation11%
Closed-won7%
$9.6KCAC
$56KLTV
5.9:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Site Laboratory Service Market is a resilient opportunity — $5.30B by 2033, compounding at 5.4%.
TAM · 2025$3.49Btoday
TAM · 2033$5.30Bforecast
CAGR5.4%2027–2033
Cumulative$39.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.30BTotal addressable market
SAM$2.19BServiceable available market
SOM$353MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.4% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.30BLarge & growingTAM by 2033 at 5.4% CAGR
$2.19BServiceable nowreachable with today’s model
$353MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.13BBear3.5% CAGR
$5.30BBase5.4% CAGR
$6.78BBull7.1% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-User Industry optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Site Laboratory Service Market — a $5.89B market by 2033. Plan: grow share from 6.6% to 11.5%.
Market size · 2033$5.89Btotal addressable
Market CAGR4.7%2027–2033
Target share11.5%from 6.6% today
Revenue ambition$678Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.6% | 11.5% | At risk |
| Revenue | $420M | $678M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 29.5% | 40.0% | Behind |
| Customer retention | 89.8% | 95.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-User Industry capability
A defensible second engine — invest in End-User Industry to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-User Industry
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $74M capacity & capability investment
- Greenlight bolt-on M&A in End-User Industry
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskAhead
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Site Laboratory Service Market conversation — a $3.92B market you can size, segment and defend in minutes.
Market size · 2033$3.92Btotal opportunity
Growth9.1%CAGR to 2033
Addressable buyers1,463+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 2 mopayback period
$96K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
LabCorp (Laboratory Corporation of America Holdings)Quest Diagnostics IncorporatedICON plcPPDInc. (Pharmaceutical Product Development)Covance Inc. (a LabCorp company)Charles River Laboratories International Inc.Eurofins Scientific+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Site Laboratory Service Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Site Laboratory Service Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Scaffold Technology Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportHospice Software Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportBiotechnology Algae Cultivation Process (Micro Algae) Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportDifferential Interference Contrast Microscopy Market
Market size, share, segmentation and regional forecast.
$744M market · 2025 base year
View reportOmega-3 Encapsulation Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportNonclinical Homecare Software Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportCognitive Data Management Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportEmbolic Prevention Systems Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportBenefits Administration Solutions Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportmiRNA Sequencing and Assay Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportDigital Health Service Market
Market size, share, segmentation and regional forecast.
$368M market · 2025 base year
View reportFood Contaminant Testing Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.